Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration
Condition(s):Dry Age Related Macular DegenerationLast Updated:May 3, 2013Suspended
Hide Studies Not Open or Pending
Condition(s):Dry Age Related Macular DegenerationLast Updated:May 3, 2013Suspended
Condition(s):Age-Related Macular DegenerationLast Updated:September 21, 2023Recruiting
Condition(s):Age Related Macular DegenerationLast Updated:September 2, 2021Completed
Condition(s):Dry Age-related Macular DegenerationLast Updated:January 24, 2024Active, not recruiting
Condition(s):Age Related Macular DegenerationLast Updated:February 18, 2021Completed
Condition(s):Age-Related (Dry) Macular DegenerationLast Updated:August 17, 2021Completed
Condition(s):Geographic Atrophy; Macular DegenerationLast Updated:February 23, 2024Completed
Condition(s):Age Related Macular DegenerationLast Updated:June 22, 2023Completed
Condition(s):Dry Age Related Macular DegenerationLast Updated:July 7, 2021Completed
Condition(s):Dry AMDLast Updated:May 9, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.